| __timestamp | Teva Pharmaceutical Industries Limited | Vertex Pharmaceuticals Incorporated |
|---|---|---|
| Wednesday, January 1, 2014 | 5078000000 | 305409000 |
| Thursday, January 1, 2015 | 4717000000 | 377080000 |
| Friday, January 1, 2016 | 5096000000 | 432829000 |
| Sunday, January 1, 2017 | 4986000000 | 496079000 |
| Monday, January 1, 2018 | 4214000000 | 557616000 |
| Tuesday, January 1, 2019 | 3806000000 | 658498000 |
| Wednesday, January 1, 2020 | 3671000000 | 770456000 |
| Friday, January 1, 2021 | 3528000000 | 840100000 |
| Saturday, January 1, 2022 | 3445000000 | 944700000 |
| Sunday, January 1, 2023 | 3498000000 | 1136600000 |
| Monday, January 1, 2024 | 3702000000 | 1464300000 |
Infusing magic into the data realm
In the competitive landscape of pharmaceuticals, understanding spending patterns is crucial. Over the past decade, Vertex Pharmaceuticals Incorporated and Teva Pharmaceutical Industries Limited have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Teva's SG&A expenses have seen a significant decline of approximately 31%, dropping from $5.08 billion to $3.50 billion. This reduction reflects Teva's strategic cost-cutting measures amidst industry challenges. Conversely, Vertex has demonstrated a robust growth trajectory, with SG&A expenses surging by nearly 272%, from $305 million to $1.14 billion. This increase underscores Vertex's aggressive expansion and investment in innovation. These divergent paths highlight the dynamic strategies employed by pharmaceutical giants to navigate market demands and sustain growth. As the industry evolves, monitoring these financial strategies offers valuable insights into the future of pharmaceutical leadership.
Breaking Down SG&A Expenses: AbbVie Inc. vs Teva Pharmaceutical Industries Limited
Comparing SG&A Expenses: Merck & Co., Inc. vs Vertex Pharmaceuticals Incorporated Trends and Insights
Operational Costs Compared: SG&A Analysis of Merck & Co., Inc. and Teva Pharmaceutical Industries Limited
Comparing SG&A Expenses: Vertex Pharmaceuticals Incorporated vs TG Therapeutics, Inc. Trends and Insights
Vertex Pharmaceuticals Incorporated or CRISPR Therapeutics AG: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Vertex Pharmaceuticals Incorporated and Galapagos NV
Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Limited: SG&A Spending Patterns Compared
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Halozyme Therapeutics, Inc.
Teva Pharmaceutical Industries Limited and ADMA Biologics, Inc.: SG&A Spending Patterns Compared
Teva Pharmaceutical Industries Limited or ACADIA Pharmaceuticals Inc.: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Teva Pharmaceutical Industries Limited or Dynavax Technologies Corporation